Delivery Order SPE2DB20D7066-SPE2DB23FC2BR
- Not listed
- This is a $3,911.18 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,568,760,460 units of XEOMIN 100 unit vials, a medication used to treat certain neurological conditions. The delivery order has a period of performance through July 31, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $18,873.00, is for the delivery of 4,566,181,768 units of XEOMIN 200 unit vials. The contract has a Firm Fixed Price pricing type and a period of performance through November 13, 2024. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,934.16, is for the delivery of 4,568,096,981 units of XEOMIN 100 unit vials. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,934.16, is for the delivery of 4,567,205,751 units of XEOMIN 200 unit vials. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,911.18 firm fixed-price delivery order is for the supply of 4,567,589,389 units of XEOMIN 100 unit vials. The contract has an ultimate completion date of April 3, 2025 and was awarded on March 13, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 200 unit vials. The firm-fixed-price contract has a ceiling value of $3,145.50 and an ultimate completion date of November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,409.76 Firm Fixed Price delivery order is for the supply of 4,567,561 units of XEOMIN 200U vials. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- This is a $44,037 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,895,525 units of XEOMIN 200 unit vials. The delivery order has an ultimate completion date of October 11, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various government agencies and healthcare programs. This award is likely part of a larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,252,859 units of the drug XEOMIN (200 unit vials). The firm-fixed-price contract has a ceiling value of $1,117.48 and an ultimate completion date of June 4, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a ceiling value of...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB23FC2BRDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,490.56, is for the delivery of 4,560,503,712 units of XEOMIN 200-unit vials. The contract has an ultimate completion date of April 25, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC, enabling efficient government procurement of essential pharmaceutical items to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.5k | 4/4/23 |